NAT2 and tuberculosis: The risk was found to be 4.62 times greater in tuberculosis patients with NAT2 hypermethylation than those with NAT2 hypomethylation (OR 4.62; 95% CI 1.12, 19.05; P = 0.034) (Table 2).